Shell Companies
Build Your Comparison
Side-by-side financial analysisStock Comparison
MACI vs GFAI vs GS vs JPM vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Financial - Capital Markets
Banks - Diversified
Financial - Capital Markets
MACI vs GFAI vs GS vs JPM vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Security & Protection Services | Financial - Capital Markets | Banks - Diversified | Financial - Capital Markets |
| Market Cap | $238M | $10M | $337.53B | $896.00B | $340.97B |
| Revenue (TTM) | $0.00 | $72M | $125.10B | $280.33B | $114.98B |
| Net Income (TTM) | $5M | $-24M | $17.18B | $57.05B | $16.86B |
| Gross Margin | — | 15.1% | 47.5% | 60.0% | 57.1% |
| Operating Margin | — | -27.4% | 17.5% | 25.9% | 19.1% |
| Forward P/E | 42.3x | — | 17.9x | 14.4x | 18.0x |
| Total Debt | $4M | $3M | $609.53B | $942.38B | $475.56B |
| Cash & Equiv. | $32K | $22M | $164.26B | $343.34B | $111.69B |
MACI vs GFAI vs GS vs JPM vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 24 | Jun 26 | Return |
|---|---|---|---|
| Melar Acquisition C… (MACI) | 100 | 110.2 | +10.2% |
| Guardforce AI Co., … (GFAI) | 100 | 22.6 | -77.4% |
| The Goldman Sachs G… (GS) | 100 | 208.8 | +108.8% |
| JPMorgan Chase & Co. (JPM) | 100 | 150.7 | +50.7% |
| Morgan Stanley (MS) | 100 | 207.4 | +107.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MACI vs GFAI vs GS vs JPM vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MACI has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and bank quality.
- Lower volatility, beta 0.01, Low D/E 2.3%, current ratio 0.91x
- NIM 4.0% vs MS's 0.7%
- Beta 0.01 vs GFAI's 2.87, lower leverage
- 2.7% ROA vs GFAI's -50.2%, ROIC -0.7% vs -41.6%
Among these 5 stocks, GFAI doesn't own a clear edge in any measured category.
GS is the clearest fit if your priority is momentum.
- +72.7% vs GFAI's -59.2%
JPM is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- PEG 0.81 vs MS's 1.88
- Lower P/E (14.4x vs 17.9x), PEG 0.81 vs 1.14
- 20.4% margin vs GFAI's -32.9%
MS ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 11.5%, EPS growth 28.3%
- 8.5% 10Y total return vs GS's 6.7%
- Beta 1.40, yield 1.9%, current ratio 1.17x
- 11.5% NII/revenue growth vs MACI's -65.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.5% NII/revenue growth vs MACI's -65.2% | |
| Value | Lower P/E (14.4x vs 17.9x), PEG 0.81 vs 1.14 | |
| Quality / Margins | 20.4% margin vs GFAI's -32.9% | |
| Stability / Safety | Beta 0.01 vs GFAI's 2.87, lower leverage | |
| Dividends | 1.9% yield, 12-year raise streak, vs JPM's 1.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +72.7% vs GFAI's -59.2% | |
| Efficiency (ROA) | 2.7% ROA vs GFAI's -50.2%, ROIC -0.7% vs -41.6% |
MACI vs GFAI vs GS vs JPM vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
MACI vs GFAI vs GS vs JPM vs MS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
GS leads 1 • MACI leads 0 • GFAI leads 0 • MS leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM and MACI operate at a comparable scale, with $280.3B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to GFAI's -32.9%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $72M | $125.1B | $280.3B | $115.0B |
| EBITDAEarnings before interest/tax | $4M | -$12M | $24.0B | $81.4B | $26.6B |
| Net IncomeAfter-tax profit | $5M | -$24M | $17.2B | $57.0B | $16.9B |
| Free Cash FlowCash after capex | -$681,989 | -$6M | -$47.2B | $100.9B | -$17.9B |
| Gross MarginGross profit ÷ Revenue | — | +15.1% | +47.5% | +60.0% | +57.1% |
| Operating MarginEBIT ÷ Revenue | — | -27.4% | +17.5% | +25.9% | +19.1% |
| Net MarginNet income ÷ Revenue | — | -32.9% | +13.7% | +20.4% | +14.7% |
| FCF MarginFCF ÷ Revenue | — | -8.8% | -37.7% | +36.0% | -15.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +3.6% | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -45.3% | +38.9% | +45.8% | +16.0% | +48.9% |
Valuation Metrics
Evenly matched — GFAI and JPM each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 62% valuation discount to MACI's 42.3x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs MS's 2.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $238M | $10M | $337.5B | $896.0B | $341.0B |
| Enterprise ValueMkt cap + debt − cash | $242M | -$10M | $782.8B | $1.50T | $704.8B |
| Trailing P/EPrice ÷ TTM EPS | 42.31x | -0.85x | 20.71x | 16.00x | 20.98x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 17.93x | 14.40x | 18.00x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.32x | 0.90x | 2.19x |
| EV / EBITDAEnterprise value multiple | — | — | 32.57x | 18.36x | 26.49x |
| Price / SalesMarket cap ÷ Revenue | — | 0.27x | 2.70x | 3.20x | 2.97x |
| Price / BookPrice ÷ Book value/share | 1.07x | 0.16x | 2.70x | 2.47x | 3.03x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 8.88x | 7.40x |
Profitability & Efficiency
Evenly matched — MACI and JPM each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-70 for GFAI. MACI carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 4.88x. On the Piotroski fundamental quality scale (0–9), MS scores 7/9 vs MACI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.9% | -69.7% | +13.6% | +15.9% | +15.3% |
| ROA (TTM)Return on assets | +2.7% | -50.2% | +1.0% | +1.3% | +1.2% |
| ROICReturn on invested capital | -0.7% | -41.6% | +2.2% | +4.5% | +3.1% |
| ROCEReturn on capital employed | -0.9% | -19.1% | +4.0% | +8.9% | +3.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.02x | 0.08x | 4.88x | 2.60x | 4.22x |
| Net DebtTotal debt minus cash | $4M | -$19M | $445.3B | $599.0B | $363.9B |
| Cash & Equiv.Liquid assets | $32,075 | $22M | $164.3B | $343.3B | $111.7B |
| Total DebtShort + long-term debt | $4M | $3M | $609.5B | $942.4B | $475.6B |
| Interest CoverageEBIT ÷ Interest expense | 5.43x | -167.24x | 0.33x | 0.74x | 0.45x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $30,053 today (with dividends reinvested), compared to $44 for GFAI. Over the past 12 months, GS leads with a +72.7% total return vs GFAI's -59.2%. The 3-year compound annual growth rate (CAGR) favors GS at 48.1% vs GFAI's -56.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.6% | -30.0% | +17.2% | -0.5% | +18.8% |
| 1-Year ReturnPast 12 months | +5.5% | -59.2% | +72.7% | +21.8% | +65.3% |
| 3-Year ReturnCumulative with dividends | +10.4% | -92.0% | +224.8% | +138.2% | +157.5% |
| 5-Year ReturnCumulative with dividends | +10.4% | -99.6% | +200.5% | +118.2% | +154.7% |
| 10-Year ReturnCumulative with dividends | +10.4% | -99.6% | +666.8% | +465.8% | +854.4% |
| CAGR (3Y)Annualised 3-year return | +3.4% | -56.9% | +48.1% | +33.6% | +37.1% |
Risk & Volatility
Evenly matched — MACI and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
MACI is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than GFAI's 2.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 97.7% from its 52-week high vs GFAI's 29.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.01x | 2.87x | 1.60x | 0.94x | 1.40x |
| 52-Week HighHighest price in past year | $11.38 | $1.50 | $1095.89 | $337.25 | $219.16 |
| 52-Week LowLowest price in past year | $10.43 | $0.38 | $609.59 | $262.71 | $128.81 |
| % of 52W HighCurrent price vs 52-week peak | +96.7% | +29.9% | +97.0% | +95.1% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 42.2 | 44.2 | 57.3 | 59.1 | 62.2 |
| Avg Volume (50D)Average daily shares traded | 18K | 758K | 1.9M | 7.0M | 4.5M |
Analyst Outlook
Evenly matched — JPM and MS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GS as "Hold", JPM as "Buy", MS as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -8.5% for GS (target: $973). For income investors, MS offers the higher dividend yield at 1.93% vs GS's 1.56%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $972.70 | $339.75 | $201.25 |
| # AnalystsCovering analysts | — | — | 55 | 61 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.6% | +1.9% | +1.9% |
| Dividend StreakConsecutive years of raises | — | — | 14 | 15 | 12 |
| Dividend / ShareAnnual DPS | — | — | $16.62 | $5.95 | $4.14 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.7% | +3.9% | +1.7% |
JPM leads in 1 of 6 categories (Income & Cash Flow). GS leads in 1 (Total Returns). 4 tied.
MACI vs GFAI vs GS vs JPM vs MS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MACI or GFAI or GS or JPM or MS a better buy right now?
For growth investors, Morgan Stanley (MS) is the stronger pick with 11.
5% revenue growth year-over-year, versus -1. 4% for The Goldman Sachs Group, Inc. (GS). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MACI or GFAI or GS or JPM or MS?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Melar Acquisition Corp. I at 42. 3x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Morgan Stanley's 1. 88x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MACI or GFAI or GS or JPM or MS?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +200. 5%, compared to -99. 6% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: MS returned +854. 4% versus GFAI's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MACI or GFAI or GS or JPM or MS?
By beta (market sensitivity over 5 years), Melar Acquisition Corp.
I (MACI) is the lower-risk stock at 0. 01β versus Guardforce AI Co. , Limited's 2. 87β — meaning GFAI is approximately 21037% more volatile than MACI relative to the S&P 500. On balance sheet safety, Melar Acquisition Corp. I (MACI) carries a lower debt/equity ratio of 2% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MACI or GFAI or GS or JPM or MS?
By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 11.
5% versus -1. 4% for The Goldman Sachs Group, Inc. (GS). On earnings-per-share growth, the picture is similar: Guardforce AI Co. , Limited grew EPS 88. 3% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MACI or GFAI or GS or JPM or MS?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -16. 1% for Guardforce AI Co. , Limited — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -18. 5% for GFAI. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MACI or GFAI or GS or JPM or MS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Morgan Stanley's 1. 88x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 18. 0x for Morgan Stanley — 3. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — MACI or GFAI or GS or JPM or MS?
In this comparison, MS (1.
9% yield), JPM (1. 9% yield), GS (1. 6% yield) pay a dividend. MACI, GFAI do not pay a meaningful dividend and should not be held primarily for income.
09Is MACI or GFAI or GS or JPM or MS better for a retirement portfolio?
For long-horizon retirement investors, Melar Acquisition Corp.
I (MACI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01)). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MACI: +10. 4%, GFAI: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MACI and GFAI and GS and JPM and MS?
These companies operate in different sectors (MACI (Financial Services) and GFAI (Industrials) and GS (Financial Services) and JPM (Financial Services) and MS (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MACI is a small-cap quality compounder stock; GFAI is a small-cap quality compounder stock; GS is a large-cap quality compounder stock; JPM is a large-cap deep-value stock; MS is a large-cap quality compounder stock. GS, JPM, MS pay a dividend while MACI, GFAI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.